September 13th, 2022
•A necessary step in anticancer aptamer development is to test its binding to the target. We demonstrate a flow cytometric-based assay to study this binding, emphasizing the importance of including a negative control aptamer and cancer cells that are positive or negative for that particular protein.
Tags
Related Videos
A Method of Targeted Cell Isolation via Glass Surface Functionalization
Fluorescent Orthotopic Mouse Model of Pancreatic Cancer
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome
Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery
Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
A Simple Migration/Invasion Workflow Using an Automated Live-cell Imager
Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved